Stockscreener 앱 받기
0.005
46.83%
-0.0155
시간 외 거래:
.01
0.005
+100.00%
전일 마감가:
$0.0205
열려 있는:
$0.0052
하루 거래량:
1.35M
Relative Volume:
66.00
시가총액:
$N/A
수익:
-
순이익/손실:
$-82.19M
주가수익비율:
-0.00161
EPS:
-3.0969
순현금흐름:
$-8.35M
1주 성능:
-46.83%
1개월 성능:
-82.86%
6개월 성능:
-98.75%
1년 성능:
-99.22%
1일 변동 폭
$0.0045
$0.0057
1주일 범위
$0.0045
$0.0057
52주 변동 폭
$0.0045
$0.0057
Ocean Biomedical Inc Stock (OCEA) Company Profile
OCEA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OCEA
Ocean Biomedical Inc
|
0.005 | 0 | 0 | -82.19M | -8.35M | -3.0969 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Ocean Biomedical Inc 주식(OCEA)의 최신 뉴스
Ocean Biomedical Faces Imminent Nasdaq Delisting - TipRanks
Delisting of Securities from The Nasdaq Stock Market - The Globe and Mail
Ocean Biomedical to be delisted from Nasdaq following appeal denial By Investing.com - Investing.com India
Ocean Biomedical to be delisted from Nasdaq following appeal denial - Investing.com
Ocean Biomedical licenses with Elkurt terminated following breach notice By Investing.com - Investing.com India
Ocean Biomedical Faces License Termination by Elkurt - TipRanks
Ocean Biomedical licenses with Elkurt terminated following breach notice - Investing.com
Ocean Biomedical faces license terminations over breaches - Investing.com
Ocean Biomedical faces license terminations over breaches By Investing.com - Investing.com Nigeria
Ocean Biomedical Faces License Termination Notice - TipRanks
SEC filing of the week: Ocean Biomedical posts $8.42M loss in Q1 - Providence Business News
Sidoti Events, LLC's Virtual June Small-Cap Conference - The Globe and Mail
Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value - Voice of Alexandria
Ocean Biomedical, Inc. SEC 10-Q Report - TradingView
Dr. Chirinjeev Kathuria - Smart Business Dealmakers
Ocean Biomedical (NASDAQ: OCEA) Announces $1 Million Falk Award for Malaria Drug Candidate Addressing Evolving Resistance to Artemisinin-Based Therapeutics to Chief Scientist Dr. Jonathan Kurtis - Seeking Alpha
Ocean Biomedical stock plunges to 52-week low of $0.28 - MSN
SEC filing of the week: Ocean Biomedical expands into energy, digital assets; delisted from Nasdaq - Providence Business News
United States shares higher at close of trade; Dow Jones Industrial Average up 1.07% - Investing.com India
Brown spinoff Ocean Biomedical, knocked off the Nasdaq, becomes a 'crypto and energy' company - The Business Journals
Ocean Biomedical expands into energy and crypto sectors - Investing.com Australia
Ocean Biomedical (OCEA) Plunges 50.00% on Diversification Shift - AInvest
why Ocean Biomedical Inc [OCEA] is a Good Choice for Investors After New Price Target of $18.50 - dbtnews.com
Ocean Biomedical expands into energy and crypto sectors By Investing.com - Investing.com South Africa
Ocean Biomedical Inc: Weathering Stock Market Storms with 6.06M Market Cap - investchronicle.com
Ocean Biomedical (OCEA) Expands into Power Infrastructure and Crypto - GuruFocus
Ocean Biomedical (OCEA) Diversifies into Power and Cryptocurrency Sectors | OCEA Stock News - GuruFocus
Ocean Biomedical Expands into Energy and Digital Asset Sectors to Accelerate Growth and Shareholder Value - The Manila Times
Ocean Biomedical Reveals Dramatic Business Transformation: Biotech Giant Expands into Energy and Digital Assets - Stock Titan
Ocean Biomedical Delays Yearly Report Filing - MSN
Ocean Biomedical stock plunges to 52-week low of $0.04 - Investing.com
Ocean Biomedical stock plunges to 52-week low of $0.04 By Investing.com - Investing.com Canada
Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Decrease in Short Interest - Defense World
Troubled Brown spinoff Ocean Biomedical racked up more losses in 2024 - The Business Journals
SEC filing of the week: Ocean Biomedical’s loss narrows to $9.4M in 2024 - Providence Business News
How does OCEA's Q3 forecast compare to past quarters? - AInvest
Ocean Biomedical, Inc. SEC 10-K Report - TradingView
Ocean Biomedical stock plunges to 52-week low of $0.05 - Investing.com
Ocean Biomedical stock plunges to 52-week low of $0.05 By Investing.com - Investing.com South Africa
Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Decline in Short Interest - Defense World
New CEO, several board members to step down from Ocean Biomedical - Providence Business News
Ocean Biomedical secures key patent in China for cancer therapy By Investing.com - Investing.com South Africa
Ocean Biomedical secures key patent in China for cancer therapy - Investing.com
Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China - The Manila Times
Ocean Biomedical Inc (OCEA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.91%
3.06%
자본화:
|
볼륨(24시간):